nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenoxybenzamine—SLC22A3—Progesterone—uterine cancer	0.313	0.414	CbGbCtD
Phenoxybenzamine—SLC22A2—Progesterone—uterine cancer	0.185	0.245	CbGbCtD
Phenoxybenzamine—SLC22A1—Progesterone—uterine cancer	0.161	0.213	CbGbCtD
Phenoxybenzamine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0446	0.059	CbGbCtD
Phenoxybenzamine—CYP3A4—Progesterone—uterine cancer	0.0296	0.0391	CbGbCtD
Phenoxybenzamine—CYP3A4—Etoposide—uterine cancer	0.0132	0.0175	CbGbCtD
Phenoxybenzamine—CYP3A4—Doxorubicin—uterine cancer	0.00902	0.0119	CbGbCtD
Phenoxybenzamine—CALM2—semen—uterine cancer	0.00755	0.0589	CbGeAlD
Phenoxybenzamine—CALM1—semen—uterine cancer	0.00752	0.0586	CbGeAlD
Phenoxybenzamine—CALM2—oviduct—uterine cancer	0.00554	0.0432	CbGeAlD
Phenoxybenzamine—CALM2—artery—uterine cancer	0.00367	0.0286	CbGeAlD
Phenoxybenzamine—CALM1—artery—uterine cancer	0.00365	0.0285	CbGeAlD
Phenoxybenzamine—CALM2—exocrine gland—uterine cancer	0.0032	0.0249	CbGeAlD
Phenoxybenzamine—CALM1—exocrine gland—uterine cancer	0.00318	0.0248	CbGeAlD
Phenoxybenzamine—ADRA1D—epithelium—uterine cancer	0.00227	0.0177	CbGeAlD
Phenoxybenzamine—CALM3—myometrium—uterine cancer	0.00226	0.0176	CbGeAlD
Phenoxybenzamine—SLC22A2—renal system—uterine cancer	0.00225	0.0176	CbGeAlD
Phenoxybenzamine—ADRA1B—renal system—uterine cancer	0.00215	0.0168	CbGeAlD
Phenoxybenzamine—SLC22A3—myometrium—uterine cancer	0.00209	0.0163	CbGeAlD
Phenoxybenzamine—CALM2—myometrium—uterine cancer	0.00177	0.0138	CbGeAlD
Phenoxybenzamine—CALM1—myometrium—uterine cancer	0.00176	0.0138	CbGeAlD
Phenoxybenzamine—CALM3—uterine cervix—uterine cancer	0.00176	0.0137	CbGeAlD
Phenoxybenzamine—CALM3—smooth muscle tissue—uterine cancer	0.00171	0.0133	CbGeAlD
Phenoxybenzamine—ADRA1D—female reproductive system—uterine cancer	0.00169	0.0132	CbGeAlD
Phenoxybenzamine—CALM3—decidua—uterine cancer	0.00167	0.0131	CbGeAlD
Phenoxybenzamine—SLC22A3—uterine cervix—uterine cancer	0.00162	0.0127	CbGeAlD
Phenoxybenzamine—SLC22A1—renal system—uterine cancer	0.00159	0.0124	CbGeAlD
Phenoxybenzamine—CALM3—endometrium—uterine cancer	0.00159	0.0124	CbGeAlD
Phenoxybenzamine—ADRA2C—myometrium—uterine cancer	0.00158	0.0124	CbGeAlD
Phenoxybenzamine—SLC22A3—smooth muscle tissue—uterine cancer	0.00158	0.0123	CbGeAlD
Phenoxybenzamine—CALM3—mammalian vulva—uterine cancer	0.00154	0.012	CbGeAlD
Phenoxybenzamine—Clomifene—CYP11A1—uterine cancer	0.00153	0.214	CrCbGaD
Phenoxybenzamine—SLC22A3—renal system—uterine cancer	0.00152	0.0119	CbGeAlD
Phenoxybenzamine—SLC22A3—endometrium—uterine cancer	0.00147	0.0115	CbGeAlD
Phenoxybenzamine—CALM3—uterus—uterine cancer	0.00146	0.0114	CbGeAlD
Phenoxybenzamine—SLC22A3—mammalian vulva—uterine cancer	0.00142	0.0111	CbGeAlD
Phenoxybenzamine—CALM2—epithelium—uterine cancer	0.00139	0.0109	CbGeAlD
Phenoxybenzamine—CALM1—epithelium—uterine cancer	0.00138	0.0108	CbGeAlD
Phenoxybenzamine—CALM2—uterine cervix—uterine cancer	0.00138	0.0108	CbGeAlD
Phenoxybenzamine—CALM1—uterine cervix—uterine cancer	0.00137	0.0107	CbGeAlD
Phenoxybenzamine—CALM2—smooth muscle tissue—uterine cancer	0.00134	0.0105	CbGeAlD
Phenoxybenzamine—CALM1—smooth muscle tissue—uterine cancer	0.00133	0.0104	CbGeAlD
Phenoxybenzamine—CALM2—decidua—uterine cancer	0.00131	0.0103	CbGeAlD
Phenoxybenzamine—CALM1—decidua—uterine cancer	0.00131	0.0102	CbGeAlD
Phenoxybenzamine—ADRA1A—epithelium—uterine cancer	0.0013	0.0102	CbGeAlD
Phenoxybenzamine—CALM2—renal system—uterine cancer	0.00129	0.0101	CbGeAlD
Phenoxybenzamine—CALM1—renal system—uterine cancer	0.00128	0.01	CbGeAlD
Phenoxybenzamine—ADRA2A—myometrium—uterine cancer	0.00126	0.00986	CbGeAlD
Phenoxybenzamine—CALM2—endometrium—uterine cancer	0.00125	0.00973	CbGeAlD
Phenoxybenzamine—CALM1—endometrium—uterine cancer	0.00124	0.00969	CbGeAlD
Phenoxybenzamine—ADRA2C—uterine cervix—uterine cancer	0.00123	0.00962	CbGeAlD
Phenoxybenzamine—SLC22A3—female reproductive system—uterine cancer	0.00122	0.00949	CbGeAlD
Phenoxybenzamine—ADRA1A—renal system—uterine cancer	0.00121	0.00944	CbGeAlD
Phenoxybenzamine—CALM2—mammalian vulva—uterine cancer	0.00121	0.00941	CbGeAlD
Phenoxybenzamine—CALM1—mammalian vulva—uterine cancer	0.0012	0.00937	CbGeAlD
Phenoxybenzamine—CALM3—female gonad—uterine cancer	0.0012	0.00934	CbGeAlD
Phenoxybenzamine—CALM3—vagina—uterine cancer	0.00119	0.00928	CbGeAlD
Phenoxybenzamine—ADRA2C—decidua—uterine cancer	0.00117	0.00916	CbGeAlD
Phenoxybenzamine—ADRA2C—renal system—uterine cancer	0.00115	0.009	CbGeAlD
Phenoxybenzamine—SLC22A1—vagina—uterine cancer	0.00115	0.00898	CbGeAlD
Phenoxybenzamine—CALM2—uterus—uterine cancer	0.00115	0.00897	CbGeAlD
Phenoxybenzamine—CALM1—uterus—uterine cancer	0.00114	0.00893	CbGeAlD
Phenoxybenzamine—ADRA2C—endometrium—uterine cancer	0.00111	0.0087	CbGeAlD
Phenoxybenzamine—SLC22A3—female gonad—uterine cancer	0.00111	0.00864	CbGeAlD
Phenoxybenzamine—SLC22A3—vagina—uterine cancer	0.0011	0.00858	CbGeAlD
Phenoxybenzamine—ADRA2C—mammalian vulva—uterine cancer	0.00108	0.00841	CbGeAlD
Phenoxybenzamine—CALM2—female reproductive system—uterine cancer	0.00103	0.00806	CbGeAlD
Phenoxybenzamine—Ospemifene—ESR1—uterine cancer	0.00103	0.144	CrCbGaD
Phenoxybenzamine—CALM1—female reproductive system—uterine cancer	0.00103	0.00802	CbGeAlD
Phenoxybenzamine—ADRA2C—uterus—uterine cancer	0.00103	0.00801	CbGeAlD
Phenoxybenzamine—ADRA2A—uterine cervix—uterine cancer	0.000984	0.00767	CbGeAlD
Phenoxybenzamine—CALM2—female gonad—uterine cancer	0.00094	0.00734	CbGeAlD
Phenoxybenzamine—ADRA2A—decidua—uterine cancer	0.000937	0.00731	CbGeAlD
Phenoxybenzamine—CALM1—female gonad—uterine cancer	0.000936	0.0073	CbGeAlD
Phenoxybenzamine—CALM2—vagina—uterine cancer	0.000935	0.00729	CbGeAlD
Phenoxybenzamine—CALM1—vagina—uterine cancer	0.00093	0.00726	CbGeAlD
Phenoxybenzamine—ADRA2A—endometrium—uterine cancer	0.00089	0.00694	CbGeAlD
Phenoxybenzamine—ADRA2A—mammalian vulva—uterine cancer	0.00086	0.00671	CbGeAlD
Phenoxybenzamine—ADRA2C—female gonad—uterine cancer	0.00084	0.00656	CbGeAlD
Phenoxybenzamine—Toremifene—ESR1—uterine cancer	0.00084	0.118	CrCbGaD
Phenoxybenzamine—ADRA2C—vagina—uterine cancer	0.000835	0.00652	CbGeAlD
Phenoxybenzamine—ADRA2A—uterus—uterine cancer	0.00082	0.0064	CbGeAlD
Phenoxybenzamine—Clomifene—CYP19A1—uterine cancer	0.000789	0.111	CrCbGaD
Phenoxybenzamine—CALM3—lymph node—uterine cancer	0.00077	0.00601	CbGeAlD
Phenoxybenzamine—ADRA2A—female reproductive system—uterine cancer	0.000737	0.00575	CbGeAlD
Phenoxybenzamine—Clomifene—ESR1—uterine cancer	0.000726	0.102	CrCbGaD
Phenoxybenzamine—CYP3A4—renal system—uterine cancer	0.000724	0.00565	CbGeAlD
Phenoxybenzamine—SLC22A3—lymph node—uterine cancer	0.000712	0.00555	CbGeAlD
Phenoxybenzamine—ADRA2A—female gonad—uterine cancer	0.000671	0.00523	CbGeAlD
Phenoxybenzamine—ADRA2A—vagina—uterine cancer	0.000666	0.0052	CbGeAlD
Phenoxybenzamine—Levomethadyl Acetate—CYP19A1—uterine cancer	0.000616	0.0864	CrCbGaD
Phenoxybenzamine—CALM2—lymph node—uterine cancer	0.000604	0.00472	CbGeAlD
Phenoxybenzamine—CALM1—lymph node—uterine cancer	0.000602	0.00469	CbGeAlD
Phenoxybenzamine—CYP3A4—female reproductive system—uterine cancer	0.00058	0.00453	CbGeAlD
Phenoxybenzamine—Tamoxifen—ESR2—uterine cancer	0.000544	0.0763	CrCbGaD
Phenoxybenzamine—ADRA2C—lymph node—uterine cancer	0.00054	0.00421	CbGeAlD
Phenoxybenzamine—ADRA2A—lymph node—uterine cancer	0.000431	0.00336	CbGeAlD
Phenoxybenzamine—Tamoxifen—CYP19A1—uterine cancer	0.000365	0.0511	CrCbGaD
Phenoxybenzamine—Methadone—CYP19A1—uterine cancer	0.000361	0.0507	CrCbGaD
Phenoxybenzamine—Tamoxifen—ESR1—uterine cancer	0.000335	0.047	CrCbGaD
Phenoxybenzamine—ADRA2B—GPCR downstream signaling—AKT1—uterine cancer	1.12e-05	0.000103	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—GPCR downstream signaling—PIK3CA—uterine cancer	1.12e-05	0.000103	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—CDKN1B—uterine cancer	1.12e-05	0.000103	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—CDKN1B—uterine cancer	1.12e-05	0.000103	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—PTEN—uterine cancer	1.12e-05	0.000103	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—PTEN—uterine cancer	1.12e-05	0.000103	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—ESR1—uterine cancer	1.12e-05	0.000103	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—ESR1—uterine cancer	1.12e-05	0.000103	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CCL2—uterine cancer	1.11e-05	0.000102	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Metabolism—EP300—uterine cancer	1.11e-05	0.000102	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—CTNNB1—uterine cancer	1.11e-05	0.000102	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—CTNNB1—uterine cancer	1.11e-05	0.000102	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—KRAS—uterine cancer	1.11e-05	0.000102	CbGpPWpGaD
Phenoxybenzamine—ADRB2—GPCR downstream signaling—AKT1—uterine cancer	1.11e-05	0.000102	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—AKT1—uterine cancer	1.11e-05	0.000102	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—EP300—uterine cancer	1.1e-05	0.000101	CbGpPWpGaD
Phenoxybenzamine—SLC22A3—Metabolism—AKT1—uterine cancer	1.1e-05	0.000101	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—NRAS—uterine cancer	1.09e-05	0.0001	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—CXCL8—uterine cancer	1.08e-05	9.96e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—CDKN1B—uterine cancer	1.08e-05	9.96e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—CDKN1B—uterine cancer	1.08e-05	9.96e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—PTEN—uterine cancer	1.08e-05	9.93e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—PTEN—uterine cancer	1.08e-05	9.93e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling by GPCR—HRAS—uterine cancer	1.08e-05	9.9e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—CTNNB1—uterine cancer	1.07e-05	9.84e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—AKT1—uterine cancer	1.07e-05	9.83e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—AKT1—uterine cancer	1.07e-05	9.83e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—CXCL8—uterine cancer	1.07e-05	9.8e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—EP300—uterine cancer	1.07e-05	9.79e-05	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—EP300—uterine cancer	1.07e-05	9.79e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Adaptive Immune System—AKT1—uterine cancer	1.06e-05	9.75e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling by GPCR—HRAS—uterine cancer	1.06e-05	9.74e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—CDKN1B—uterine cancer	1.06e-05	9.73e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—CTNNB1—uterine cancer	1.06e-05	9.72e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—CTNNB1—uterine cancer	1.06e-05	9.71e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—NRAS—uterine cancer	1.06e-05	9.7e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—NRAS—uterine cancer	1.06e-05	9.7e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—GPCR downstream signaling—AKT1—uterine cancer	1.05e-05	9.62e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—VEGFA—uterine cancer	1.04e-05	9.59e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—PTEN—uterine cancer	1.04e-05	9.59e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—CDKN1B—uterine cancer	1.04e-05	9.57e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—GPCR downstream signaling—PIK3CA—uterine cancer	1.04e-05	9.57e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—PTEN—uterine cancer	1.03e-05	9.48e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—NRAS—uterine cancer	1.03e-05	9.47e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—EP300—uterine cancer	1.03e-05	9.47e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—EP300—uterine cancer	1.03e-05	9.47e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—GPCR downstream signaling—AKT1—uterine cancer	1.03e-05	9.47e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—PTEN—uterine cancer	1.03e-05	9.47e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—KRAS—uterine cancer	1.03e-05	9.46e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Adaptive Immune System—AKT1—uterine cancer	1.03e-05	9.44e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Adaptive Immune System—AKT1—uterine cancer	1.03e-05	9.44e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—CTNNB1—uterine cancer	1.02e-05	9.41e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—CTNNB1—uterine cancer	1.02e-05	9.41e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling by GPCR—AKT1—uterine cancer	1.02e-05	9.35e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—PIK3CA—uterine cancer	1.02e-05	9.35e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CCL2—uterine cancer	1.02e-05	9.34e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling by GPCR—AKT1—uterine cancer	1.01e-05	9.23e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—CTNNB1—uterine cancer	1e-05	9.19e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—ERBB2—uterine cancer	9.99e-06	9.18e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—PTEN—uterine cancer	9.98e-06	9.17e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—PTEN—uterine cancer	9.98e-06	9.17e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—NRAS—uterine cancer	9.97e-06	9.16e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—EP300—uterine cancer	9.95e-06	9.14e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—CTNNB1—uterine cancer	9.84e-06	9.04e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—EP300—uterine cancer	9.84e-06	9.04e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CCL2—uterine cancer	9.83e-06	9.03e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CCL2—uterine cancer	9.83e-06	9.03e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—EP300—uterine cancer	9.83e-06	9.03e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—PTEN—uterine cancer	9.75e-06	8.96e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—STK11—uterine cancer	9.65e-06	8.87e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—CYP19A1—uterine cancer	9.65e-06	8.87e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—NRAS—uterine cancer	9.65e-06	8.86e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—NRAS—uterine cancer	9.65e-06	8.86e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—PTEN—uterine cancer	9.6e-06	8.81e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—EP300—uterine cancer	9.52e-06	8.74e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—EP300—uterine cancer	9.52e-06	8.74e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling by GPCR—AKT1—uterine cancer	9.51e-06	8.74e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—CXCL8—uterine cancer	9.48e-06	8.71e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—PTEN—uterine cancer	9.47e-06	8.7e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—PIK3CA—uterine cancer	9.46e-06	8.69e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—VEGFA—uterine cancer	9.43e-06	8.66e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—HRAS—uterine cancer	9.42e-06	8.65e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—KRAS—uterine cancer	9.39e-06	8.63e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling by GPCR—AKT1—uterine cancer	9.36e-06	8.6e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—NRAS—uterine cancer	9.31e-06	8.55e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—VEGFA—uterine cancer	9.31e-06	8.55e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—EP300—uterine cancer	9.3e-06	8.54e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—ERBB2—uterine cancer	9.29e-06	8.53e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—CDKN1B—uterine cancer	9.26e-06	8.5e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—NRAS—uterine cancer	9.21e-06	8.46e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—NRAS—uterine cancer	9.19e-06	8.44e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—GPCR downstream signaling—AKT1—uterine cancer	9.16e-06	8.41e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—EP300—uterine cancer	9.15e-06	8.41e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—KRAS—uterine cancer	9.09e-06	8.35e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—KRAS—uterine cancer	9.09e-06	8.35e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—EP300—uterine cancer	9.03e-06	8.3e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—NRAS—uterine cancer	8.9e-06	8.18e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—NRAS—uterine cancer	8.9e-06	8.18e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—KRAS—uterine cancer	8.88e-06	8.15e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CXCL8—uterine cancer	8.81e-06	8.09e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—VEGFA—uterine cancer	8.81e-06	8.09e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—HRAS—uterine cancer	8.75e-06	8.04e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—CTNNB1—uterine cancer	8.74e-06	8.03e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—NRAS—uterine cancer	8.7e-06	7.99e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—VEGFA—uterine cancer	8.67e-06	7.96e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—PTEN—uterine cancer	8.64e-06	7.94e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—PIK3CA—uterine cancer	8.63e-06	7.93e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CDKN1B—uterine cancer	8.6e-06	7.9e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—KRAS—uterine cancer	8.58e-06	7.88e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—NRAS—uterine cancer	8.56e-06	7.86e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—PTEN—uterine cancer	8.52e-06	7.83e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—GPCR downstream signaling—AKT1—uterine cancer	8.51e-06	7.81e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—ERBB2—uterine cancer	8.47e-06	7.78e-05	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Metabolism—PIK3CA—uterine cancer	8.46e-06	7.77e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—PTEN—uterine cancer	8.36e-06	7.68e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—PTEN—uterine cancer	8.36e-06	7.68e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—PIK3CA—uterine cancer	8.35e-06	7.67e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—PIK3CA—uterine cancer	8.35e-06	7.67e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—AKT1—uterine cancer	8.31e-06	7.64e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—KRAS—uterine cancer	8.3e-06	7.63e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—KRAS—uterine cancer	8.3e-06	7.63e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—EP300—uterine cancer	8.24e-06	7.57e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Metabolism—PIK3CA—uterine cancer	8.23e-06	7.56e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—ERBB2—uterine cancer	8.2e-06	7.53e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—ERBB2—uterine cancer	8.2e-06	7.53e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—PIK3CA—uterine cancer	8.16e-06	7.49e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—EP300—uterine cancer	8.13e-06	7.47e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CTNNB1—uterine cancer	8.12e-06	7.46e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CXCL8—uterine cancer	8.04e-06	7.38e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—KRAS—uterine cancer	8.01e-06	7.36e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—HRAS—uterine cancer	7.98e-06	7.33e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—EP300—uterine cancer	7.97e-06	7.32e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—EP300—uterine cancer	7.97e-06	7.32e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—KRAS—uterine cancer	7.92e-06	7.28e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—PTEN—uterine cancer	7.92e-06	7.27e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—KRAS—uterine cancer	7.91e-06	7.27e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—TP53—uterine cancer	7.89e-06	7.25e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—PIK3CA—uterine cancer	7.88e-06	7.24e-05	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—PIK3CA—uterine cancer	7.88e-06	7.24e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CDKN1B—uterine cancer	7.85e-06	7.21e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CXCL8—uterine cancer	7.77e-06	7.14e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CXCL8—uterine cancer	7.77e-06	7.14e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—AKT1—uterine cancer	7.73e-06	7.1e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—HRAS—uterine cancer	7.72e-06	7.09e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—HRAS—uterine cancer	7.72e-06	7.09e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—VEGFA—uterine cancer	7.7e-06	7.07e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—KRAS—uterine cancer	7.66e-06	7.04e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—KRAS—uterine cancer	7.66e-06	7.04e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—PIK3CA—uterine cancer	7.63e-06	7.01e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—PIK3CA—uterine cancer	7.63e-06	7.01e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—NRAS—uterine cancer	7.6e-06	6.98e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CDKN1B—uterine cancer	7.59e-06	6.97e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CDKN1B—uterine cancer	7.59e-06	6.97e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—EP300—uterine cancer	7.55e-06	6.94e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—HRAS—uterine cancer	7.55e-06	6.93e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—KRAS—uterine cancer	7.49e-06	6.88e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CTNNB1—uterine cancer	7.41e-06	6.81e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—KRAS—uterine cancer	7.37e-06	6.77e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—PIK3CA—uterine cancer	7.36e-06	6.76e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—HRAS—uterine cancer	7.29e-06	6.7e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—PIK3CA—uterine cancer	7.28e-06	6.69e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—PIK3CA—uterine cancer	7.27e-06	6.68e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—MTHFR—uterine cancer	7.25e-06	6.66e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—PTEN—uterine cancer	7.23e-06	6.64e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CTNNB1—uterine cancer	7.17e-06	6.59e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CTNNB1—uterine cancer	7.17e-06	6.59e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—VEGFA—uterine cancer	7.15e-06	6.57e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—TP53—uterine cancer	7.12e-06	6.54e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—NRAS—uterine cancer	7.07e-06	6.49e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—HRAS—uterine cancer	7.06e-06	6.48e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—HRAS—uterine cancer	7.06e-06	6.48e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—AKT1—uterine cancer	7.05e-06	6.48e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—PIK3CA—uterine cancer	7.04e-06	6.47e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—PIK3CA—uterine cancer	7.04e-06	6.47e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—TP53—uterine cancer	7.03e-06	6.46e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—PTEN—uterine cancer	6.99e-06	6.42e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—PTEN—uterine cancer	6.99e-06	6.42e-05	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Metabolism—AKT1—uterine cancer	6.91e-06	6.35e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—EP300—uterine cancer	6.89e-06	6.33e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—PIK3CA—uterine cancer	6.88e-06	6.32e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—AKT1—uterine cancer	6.82e-06	6.26e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—AKT1—uterine cancer	6.82e-06	6.26e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—HRAS—uterine cancer	6.81e-06	6.26e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—PIK3CA—uterine cancer	6.77e-06	6.22e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—HRAS—uterine cancer	6.73e-06	6.19e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—HRAS—uterine cancer	6.73e-06	6.18e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Metabolism—AKT1—uterine cancer	6.72e-06	6.17e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—PIK3CA—uterine cancer	6.68e-06	6.14e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—EP300—uterine cancer	6.67e-06	6.12e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—EP300—uterine cancer	6.67e-06	6.12e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—AKT1—uterine cancer	6.66e-06	6.12e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—TP53—uterine cancer	6.65e-06	6.11e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—TP53—uterine cancer	6.55e-06	6.02e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—KRAS—uterine cancer	6.54e-06	6.01e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—VEGFA—uterine cancer	6.53e-06	6e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—HRAS—uterine cancer	6.51e-06	5.98e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—HRAS—uterine cancer	6.51e-06	5.98e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—NRAS—uterine cancer	6.45e-06	5.92e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—AKT1—uterine cancer	6.44e-06	5.92e-05	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—AKT1—uterine cancer	6.44e-06	5.91e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—HRAS—uterine cancer	6.36e-06	5.85e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—VEGFA—uterine cancer	6.31e-06	5.8e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—VEGFA—uterine cancer	6.31e-06	5.8e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—HRAS—uterine cancer	6.26e-06	5.75e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—NRAS—uterine cancer	6.24e-06	5.73e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—NRAS—uterine cancer	6.24e-06	5.73e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—AKT1—uterine cancer	6.23e-06	5.72e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—AKT1—uterine cancer	6.23e-06	5.72e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—PIK3CA—uterine cancer	6.1e-06	5.6e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—KRAS—uterine cancer	6.08e-06	5.59e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—AKT1—uterine cancer	6.02e-06	5.53e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—PIK3CA—uterine cancer	6.01e-06	5.52e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—AKT1—uterine cancer	5.95e-06	5.46e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—AKT1—uterine cancer	5.94e-06	5.45e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—PIK3CA—uterine cancer	5.9e-06	5.42e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—PIK3CA—uterine cancer	5.9e-06	5.42e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—TP53—uterine cancer	5.82e-06	5.34e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—AKT1—uterine cancer	5.75e-06	5.28e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—AKT1—uterine cancer	5.75e-06	5.28e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—AKT1—uterine cancer	5.62e-06	5.16e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—PIK3CA—uterine cancer	5.59e-06	5.13e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—HRAS—uterine cancer	5.56e-06	5.11e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—KRAS—uterine cancer	5.55e-06	5.1e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—AKT1—uterine cancer	5.53e-06	5.08e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—AKT1—uterine cancer	5.46e-06	5.01e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—TP53—uterine cancer	5.4e-06	4.96e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—KRAS—uterine cancer	5.37e-06	4.93e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—KRAS—uterine cancer	5.37e-06	4.93e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—HRAS—uterine cancer	5.17e-06	4.75e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—PIK3CA—uterine cancer	5.1e-06	4.68e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—AKT1—uterine cancer	4.98e-06	4.57e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—TP53—uterine cancer	4.93e-06	4.53e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—PIK3CA—uterine cancer	4.93e-06	4.53e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—PIK3CA—uterine cancer	4.93e-06	4.53e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—AKT1—uterine cancer	4.91e-06	4.51e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—AKT1—uterine cancer	4.82e-06	4.43e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—AKT1—uterine cancer	4.82e-06	4.43e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—TP53—uterine cancer	4.77e-06	4.38e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—TP53—uterine cancer	4.77e-06	4.38e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—HRAS—uterine cancer	4.72e-06	4.33e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—AKT1—uterine cancer	4.56e-06	4.19e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—HRAS—uterine cancer	4.56e-06	4.19e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—HRAS—uterine cancer	4.56e-06	4.19e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—AKT1—uterine cancer	4.16e-06	3.83e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—PTEN—uterine cancer	4.03e-06	3.71e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—AKT1—uterine cancer	4.03e-06	3.7e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—AKT1—uterine cancer	4.03e-06	3.7e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—EP300—uterine cancer	3.85e-06	3.53e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—PIK3CA—uterine cancer	2.85e-06	2.61e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—AKT1—uterine cancer	2.33e-06	2.14e-05	CbGpPWpGaD
